Axcella Health Inc.
Axcella Health Inc. operates as a clinical stage biotechnology company in the United States. The company treats complex diseases and enhances health using endogenous metabolic modulator compositions. Its lead product candidates include AXA1665, which is …
Biotechnology
US, Cambridge [HQ]
Cash Flow Statements
6 Records · Starting from 2017In Million USD. Margins, Growth Rates In %
| Metric | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | |
|---|---|---|---|---|---|---|---|
| Operating Activities | |||||||
| Operating Cash Flow (OCF) | -26.00 | -30.00 | - - | - - | - - | - - | |
| Operating Cash (Net) | -26.00 | -30.00 | - - | - - | - - | - - | |
| Accounts Receivable | - - | - - | - - | - - | - - | - - | |
| Accounts Payable | - - | - - | - - | - - | - - | - - | |
|
Working Capital
|
- - | - - | - - | - - | - - | - - | |
| Change | 1.00 | 1.00 | - - | - - | - - | - - | |
| Other WC | 1.00 | - - | - - | - - | - - | - - | |
| Investing Activities | |||||||
| Used Cash (Net) | - - | - - | - - | - - | - - | - - | |
| Capital Expenditure | -1.00 | - - | - - | - - | - - | - - | |
| Purchases of Investments | - - | - - | - - | - - | - - | - - | |
| Sale/Maturity of Investment | - - | - - | - - | - - | - - | - - | |
| Property, Plant, Equipment (P&PE) | -1.00 | - - | - - | - - | - - | - - | |
| Acquisitions (Net) | - - | - - | - - | - - | - - | - - | |
| Other Investing Activities | - - | - - | - - | - - | - - | - - | |
| Financing Activities | |||||||
| Used Cash (Net) | -25.00 | -63.00 | - - | - - | - - | - - | |
| Debt Repayment | - - | - - | - - | - - | - - | - - | |
| Dividends Paid | - - | - - | - - | - - | - - | - - | |
|
Common Stock
|
- - | - - | - - | - - | - - | - - | |
| Issued | - - | - - | - - | - - | - - | - - | |
| Repurchased | - - | - - | - - | - - | - - | - - | |
| Other Financing Activities | 25.00 | 63.00 | - - | - - | - - | - - | |
| Cash Balances | |||||||
| Begin of Period | 48.00 | 46.00 | - - | - - | - - | - - | |
| End of Period | 46.00 | 79.00 | - - | - - | - - | - - | |
| Change | -2.00 | 32.00 | - - | - - | - - | - - | |
| Non-Cash Balances | |||||||
| Depreciation and Amortization | 1.00 | 1.00 | - - | - - | - - | - - | |
| Stock Based Compensation | 1.00 | 2.00 | - - | - - | - - | - - | |
| Other | - - | - - | - - | - - | - - | - - | |
| Highlighted metrics | |||||||
| Free Cash Flow (FCF) | -27.00 | -31.00 | - - | - - | - - | - - | |
| Cash Conversion Cycle (CCC) | - - | - - | - - | - - | - - | - - | |
| Invested Capital | - - | - - | - - | - - | - - | - - | |
|
Other Operating Inflows/Outflows
|
|||||||
| Forex Effect on Cash | - - | - - | - - | - - | - - | - - |